Pure Global
Disease/Condition
375 Clinical Trials
10+ Countries

Prostate cancer Clinical Trials Database - Free Access to 375 Studies

Access comprehensive clinical trial information for Prostate cancer through Pure Global AI's free database. This collection includes 375 clinical trials across multiple phases including N/A, Not Applicable, Phase 2. Currently, 110 trials are actively recruiting participants.

Research for Prostate cancer is being conducted in Japan, China, Australia and 7+ other countries. Leading sponsors include Qilu Hospital of Shandong University and Edith Cowan University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
176
Not Applicable
73
Phase 2
49
Early Phase 1
36
Phase 3
15
By Status
Recruiting
110
Completed
102
Not yet recruit...
63
Unknown
31
Recruitment Com...
26
Top Countries
Japan137
China93
Australia43
Netherlands17
United Kingdom9
Top Sponsors
Qilu Hospital of S...4
Edith Cowan Univer...4
Tohoku University4
Chinese PLA Genera...4
Department of Urol...3
Recent Trials
Latest clinical trials for Prostate cancer
2020-000543-31

An Adaptive Phase 2, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a Gonadotropin-releasing Hormone (GnRH) A...

Antev Ltd.
UMIN000050538
Recruiting

Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study

Aichi Medical UniversityJapan
jRCT2031220674
Recruiting

Untitled Trial

Astellas Pharma Global Develop...United States of America;Argentina;Australia;Belgium;Canada;Chile;Czech;Denmark;Finland;France;Georg
ANZCTR12623000160639
Phase 2
Not yet recr...

A Randomized, Open-Label, Phase 2 Study of Darolutamide as Single Agent or in Combination with EPI-7386 as a Neoadjuvant Treatment for Patients Undergoing Prostatectomy for Localized Prostate Cancer (DaSCENT)

St Vincent's Hospital SydneyAustralia
ANZCTR12623000073606
Early Phase 1
Not yet recr...

A Single-Arm, Open-Label, Prospective, Phase 0 Trial Evaluating the Safety and Efficacy of Salvage 177Lu-PSMA-I&T in Prostate Specific Antigen (PSA) Biochemical Failure After Radical Prostatectomy for High-Risk Prostate Cancer

Dr Anthony-Joe NassourAustralia
UMIN000049746
Phase 2
Recruiting

A Confirmatory Clinical Trial of Two-fractionated Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Prostate Cancer Patients

National Cancer CenterJapan
ANZCTR12622001478707
Not Applicable
Not yet recr...

Evaluating the efficacy of radiation therapy compared to surveillance in men with prostate cancer that has returned after surgery and negative Prostate specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scan.

The Australian and New Zealand...Australia
UMIN000049304
Enrolling by...

Randomized Phase II selection trial of Stereotactic Prostate Irradiation with Dose Escalated Region

Kitasato univeristyJapan
jRCT1032220391
Recruiting

Untitled Trial

2022-001410-20
Ongoing

Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer

Radboud university medical cen...
ChiCTR2200062729
Recruiting

Untitled Trial

Department of urology, The Fir...China
UMIN000047981
Not yet recr...

Effect of tadarafil on lower urinary tract symptoms in patients treated with low dose rate brachytherapy for prostate cancer

Nara Medical UniversityJapan
ChiCTR2200060566
Phase 2
Not yet recr...

Untitled Trial

Qilu Hospital of Shandong Univ...China
jRCT2031220104
Recruitment ...

Untitled Trial

Novartis Pharma. K.K.United States of America;Austria;Belgium;Canada;Denmark;France;South Korea;Netherlands;Poland;Singap
jRCTs052220034
Recruitment ...

Untitled Trial

UMIN000047536
Recruiting

Biochemical adaptive radiation therapy based on prostate-specific antigen response in salvage radiation therapy for postoperative biochemical failure of prostate cancer.

Kamagaya General HospitalJapan
2021-000486-33
Ongoing

99mTc-MIP-1404 SPECT/CT for primary PROstate cancer STAging: comparative prospective, randomized trial to present guideline imaging

Turku University Hospital
ChiCTR2200057223
Not Applicable
Not yet recr...

Untitled Trial

Sun Yat-Sen Memorial Hospital ...China
ChiCTR2200056386
Not Applicable
Not yet recr...

Untitled Trial

The first affiliated hospital ...China
ChiCTR2200055401
Not Applicable
Not yet recr...

Untitled Trial

Sichuan Cancer HospitalChina
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Prostate cancer Research

Pure Global AI provides free access to 375 clinical trials studying Prostate cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Qilu Hospital of Shandong University, Edith Cowan University, Tohoku University, among others.

Quick Facts
Total Trials375
Countries10+
Sponsors10+
Recruiting110